Comparison of efficacy and safety of epalrestat with methylcobalamin in patients with diabetic neuropathy
@inproceedings{Preeth2018ComparisonOE,
title={Comparison of efficacy and safety of epalrestat with methylcobalamin in patients with diabetic neuropathy},
author={C. Preeth},
year={2018}
}BACKGROUND:
Diabetic neuropathy is a common complication that develops in nearly 50% of over all diabetes population especially long standing hyperglycemic patients. Diabetic neuropathy appears relatively early in the disease process. The prevalence of upto 7% is reported in South Indian patients even at the time of diagnosis of diabetes. Though precise mechanism of neuronal damage is unclear, accumulation of excess sorbitol through polyol pathway is supportive evidence. Recently Epalrestat… CONTINUE READING
Figures, Tables, and Topics from this paper
Figures and Tables
figure 1 
table 1 
figure 2 
table 2 
figure 3 
table 3 
figure 4 
table 4 
figure 5 
table 5 
table 6 
table 7 
table 8 
figure 9 
table 9 
figure 10 
table 10 
figure 11 
table 11 
figure 12 
table 12 
figure 13 
table 13 
figure 14 
table 14 
figure 15 
table 15 
figure 16 
table 16 
figure 17 
table 17 
figure 18 
table 18 
figure 19 
table 19 
figure 20 
table 20 
figure 21 
figure 22
References
SHOWING 1-10 OF 59 REFERENCES
Evaluation of efficacy and safety of epalrestat and epalrestat in combination with methylcobalamin in patients with diabetic neuropathy in a randomized, comparative trial
- Computer Science
- 2013
- 5
- PDF
Effects of epalrestat combined with methylcobalamin on diabetic peripheral neuropathy:a Meta-analysis
- Medicine
- 2012
- 1
Efficacy, safety, and tolerability of Epalrestat compared to Methylcobalamine in patients with diabetic neuropathy
- Medicine
- International journal of diabetes in developing countries
- 2009
- 12
Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy
- Medicine
- Pharmacotherapy
- 2008
- 150
Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
- Medicine
- Annals of Indian Academy of Neurology
- 2008
- 28
A prospective, open label, 24-week trial of methylcobalamin in the treatment of diabetic polyneuropathy
- Computer Science
- 2012
- 9
- PDF
Efficacy and Tolerability of a Fixed Dose Combination of Methylcobalamin and Pregabalin in the Management of Painful Neuropathy
- Medicine
- North American journal of medical sciences
- 2012
- 7
Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients.
- Medicine
- Internal medicine
- 1999
- 80
Clinical usefulness of intrathecal injection of methylcobalamin in patients with diabetic neuropathy.
- Medicine
- Clinical therapeutics
- 1987
- 46
Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy
- Medicine
- Diabetes Care
- 2006
- 213
- PDF